BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 25307995)

  • 1. Idiopathic recurrent pericarditis as an immune-mediated disease: current insights into pathogenesis and emerging treatment options.
    Imazio M
    Expert Rev Clin Immunol; 2014 Nov; 10(11):1487-92. PubMed ID: 25307995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent pericarditis: new and emerging therapeutic options.
    Imazio M; Lazaros G; Brucato A; Gaita F
    Nat Rev Cardiol; 2016 Feb; 13(2):99-105. PubMed ID: 26259934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent Pericarditis: Modern Approach in 2016.
    Imazio M; Adler Y; Charron P
    Curr Cardiol Rep; 2016 Jun; 18(6):50. PubMed ID: 27108360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing acute and recurrent idiopathic pericarditis.
    Schwier NC; Cornelio CK; Epperson TM
    JAAPA; 2020 Jan; 33(1):16-22. PubMed ID: 31880644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of acute and recurrent pericarditis. What the clinical cardiologist should know].
    Imazio M; Trinchero R
    G Ital Cardiol (Rome); 2008 Dec; 9(12):826-34. PubMed ID: 19119692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and Recurrent Pericarditis.
    Imazio M; Gaita F
    Cardiol Clin; 2017 Nov; 35(4):505-513. PubMed ID: 29025542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent pericarditis.
    Imazio M; Battaglia A; Gaido L; Gaita F
    Rev Med Interne; 2017 May; 38(5):307-311. PubMed ID: 28185680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism.
    Brucato A; Emmi G; Cantarini L; Di Lenarda A; Gattorno M; Lopalco G; Marcolongo R; Imazio M; Martini A; Prisco D
    Intern Emerg Med; 2018 Jun; 13(4):475-489. PubMed ID: 29633070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial.
    Imazio M; Bobbio M; Cecchi E; Demarie D; Demichelis B; Pomari F; Moratti M; Gaschino G; Giammaria M; Ghisio A; Belli R; Trinchero R
    Circulation; 2005 Sep; 112(13):2012-6. PubMed ID: 16186437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenetic mechanisms, new drugs, and old problems in idiopathic recurrent pericarditis: comment on the article by Picco et al.
    Brucato A; Imazio M; Spodick D; Adler Y
    Arthritis Rheum; 2009 Aug; 60(8):2543; author reply 2543-4. PubMed ID: 19644862
    [No Abstract]   [Full Text] [Related]  

  • 11. Incessant and recurrent pericarditis: Corticosteroids or novel immune-suppressants agents.
    Tousoulis D
    Hellenic J Cardiol; 2019; 60(6):345-346. PubMed ID: 32252971
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacotherapy update of acute idiopathic pericarditis.
    Schwier NC; Coons JC; Rao SK
    Pharmacotherapy; 2015 Jan; 35(1):99-111. PubMed ID: 25630413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent pericarditis in children and adolescents: a multicentre cohort study.
    Imazio M; Brucato A; Pluymaekers N; Breda L; Calabri G; Cantarini L; Cimaz R; Colimodio F; Corona F; Cumetti D; Cuccio CD; Gattorno M; Insalaco A; Limongelli G; Russo MG; Valenti A; Finkelstein Y; Martini A
    J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):707-12. PubMed ID: 27467459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and management of pericarditis.
    Imazio M
    Expert Rev Cardiovasc Ther; 2011 Sep; 9(9):1221-33. PubMed ID: 21932964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?
    Picco P; Brisca G; Traverso F; Loy A; Gattorno M; Martini A
    Arthritis Rheum; 2009 Jan; 60(1):264-8. PubMed ID: 19116906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis.
    Jain S; Thongprayoon C; Espinosa RE; Hayes SN; Klarich KW; Cooper LT; Moder KG; Anavekar NS; Oh JK; Matteson EL
    Am J Cardiol; 2015 Oct; 116(8):1277-9. PubMed ID: 26279106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of an interleukin-1β receptor antagonist (anakinra) in idiopathic recurrent pericarditis.
    Scardapane A; Brucato A; Chiarelli F; Breda L
    Pediatr Cardiol; 2013; 34(8):1989-91. PubMed ID: 23052671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of subacute constrictive pericarditis with interleukin-1β receptor antagonist (anakinra).
    D'Elia E; Brucato A; Pedrotti P; Valenti A; De Amici M; Fiocca L; Duino V; Senni M; Imazio M; Martini A
    Clin Exp Rheumatol; 2015; 33(2):294-5. PubMed ID: 25664579
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical therapy of pericardial diseases: part I: idiopathic and infectious pericarditis.
    Imazio M; Brucato A; Mayosi BM; Derosa FG; Lestuzzi C; Macor A; Trinchero R; Spodick DH; Adler Y
    J Cardiovasc Med (Hagerstown); 2010 Oct; 11(10):712-22. PubMed ID: 20736783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights in the pathogenesis and therapy of idiopathic recurrent pericarditis in children.
    Gaspari S; Marsili M; Imazio M; Brucato A; Di Blasi Lo Cuccio C; Chiarelli F; Breda L
    Clin Exp Rheumatol; 2013; 31(5):788-94. PubMed ID: 23981280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.